Mai Capital Management Natera, Inc. Put Options Transaction History

Mai Capital Management

4 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2022 May 10, 2022	SELL	$30.32 - $91.33 $142,504 - $429,251	-4,700 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$100.17 - $126.36 $280,476 - $353,808	-2,800 Reduced 37.33%	4,700 $524,000
Q2 2021 Jul 19, 2021	SELL	$86.05 - $119.72 $129,075 - $179,580	-1,500 Reduced 16.67%	7,500 $851,000
Q1 2021 May 10, 2021	BUY	$91.47 - $124.36 $823,230 - $1.12 Million	9,000 New	9,000 $914,000

528

119M

308K

191K

Ticker NTRA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 96,957,400
Market Cap $16.3B
Description
Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...

Get notified when there are updates to the investment portfolio of Mai Capital Management, based on Form 13F filings with the SEC.

Stay updated on Mai Capital Management with notifications on news.